Form 8-K - Current report:
SEC Accession No. 0000950120-07-000057
Filing Date
2007-01-25
Accepted
2007-01-25 16:56:23
Documents
2
Period of Report
2007-01-21
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K - DATE OF REPORT 1/21/07 form8k.htm 8-K 38277
2 EXHIBIT 99.1 - RESTATEMENT OF 2003 CONSOLIDATED FINANCIAL STATEMENTS exh99_1.htm EX-99.1 293364
  Complete submission text file 0000950120-07-000057.txt   333199
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

EIN.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19879 | Film No.: 07553616
SIC: 2834 Pharmaceutical Preparations